Primary immunodeficiency diseases worldwide: more common than generally thought.
about
Humoral immunodeficiency : awareness for better supportFirst report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012)Primary subacute epiphyseal osteomyelitis caused by Mycobacterium species in young children: a modern diagnostic approach.Next Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders - Future Directions.Health-Related Quality of Life in Adult Patients with Common Variable Immunodeficiency Disorders and Impact of TreatmentA phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedsideTargeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDs.Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).Perceived Health in Patients with Primary Immune Deficiency.The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.Family Physician Perspectives on Primary Immunodeficiency DiseasesPrevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007.Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening StudyThe plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency.Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry.Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies.Hizentra for the treatment of primary immunodeficiency.Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.Diagnostic Delay of Primary Immunodeficiencies at a Tertiary Care Hospital in Peru- Brief Report.Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases.Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.Primary Immunodeficiency Diseases: Current and Emerging Therapeutics.Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies.Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals' Quality of Life and the Sustainability of Health-care Systems.Medical awareness concerning primary immunodeficiency diseases in the city of São Paulo, BrazilPathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies.Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.Calculating the dose of subcutaneous immunoglobulin for primary immunodeficiency disease in patients switched from intravenous to subcutaneous immunoglobulin without the use of a dose-adjustment coefficient.Development of Primary Immunodeficiencies in Africa.The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies.Collaborating to improve quality of life in primary immunodeficiencies: World PI Week, 2013.Exercise Perception and Behaviors in Individuals Living with Primary Immunodeficiency Disease.Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg.Gammaplex® 5 and 10% in the treatment of primary immunodeficiency and chronic immune thrombocytopenic purpura.
P2860
Q26859051-7FEFAB58-D399-4E08-8F41-2679005EE3D1Q28235781-59D36BCD-69D0-48F8-87FE-EA919B569BCEQ30397080-56B48F37-AB0B-48FE-ADCE-43BFF010BBE5Q31060798-E67619E6-3649-4671-9B61-5E97BD3C247FQ33849464-601AA971-D6C3-4945-8A70-5A5168834DA6Q33852585-8D40A4E4-3DB8-4414-BBB7-74BF4250233AQ34442687-397842B4-9C38-4621-B709-F070FCFE0D20Q35779733-A0D586D0-4139-4140-9E5A-51DB9674568DQ36065390-2C1F7348-268F-4664-8992-9947198F7CF2Q36234369-5A7E5231-D2E4-4615-9DAE-13ED916A1BA3Q36319931-6D6EED1F-C7FB-4252-96BD-ABBD608050E7Q36740401-BB27E939-CE63-45ED-804C-FAAE01F07816Q36763235-FF193CE4-D551-4127-88B6-610D697E893DQ36993399-2178506F-FF18-4A43-A49C-428351EE73D7Q37542082-B4F295F9-F2E4-4E90-958B-E5CC0D2158C9Q37580857-C052D7D2-6CBC-45A0-B250-4865E77EF930Q37591931-F3EEB9AF-940A-4AC6-ADC3-6D6D4FB1561FQ37666847-2D47BBBA-AA09-40F1-BAAF-E797F17CA863Q38217591-9F89B89C-EBF7-46F7-8545-A4E30784690CQ38245612-00297130-2F30-490A-B5BB-6894CF1E95B8Q38398798-00E30BBC-446E-47A5-BF29-EBE1E68EBC70Q38533817-1A179CE7-3C9F-4995-BC6E-7D49A612835FQ38796641-6452A44A-9515-4A4C-967D-81CA38D4C092Q39981373-869703BB-F7FC-4CE8-8C4A-3BCBBF34F195Q40066943-3516A7C8-80D0-4CF8-B830-941003835F01Q40070985-FF59BF49-ECEF-47C5-8CE1-E10AC376BA11Q40076704-7134ABDA-3A74-42E7-BD3D-88225559A4E5Q40101187-2608CAF0-E631-44A7-938A-67F2A57B7833Q40517818-C8C21E29-32BF-445A-8C78-CEE78140F9E2Q41810269-75517204-435E-4EA6-964B-A1EC1239FAEDQ41810515-B14F2485-F16A-48C7-8DE4-59B65677F308Q41989467-70E439CE-DA48-4694-AFE8-E9FBB4BAAA8CQ42225641-64021C2A-7F4D-4B6A-AA07-65F906AA4256Q42771212-244D3BC8-7F64-41A1-9413-9EE33D90FDC8Q43477598-258724C4-5F94-48C3-BF6B-D5D2E22FFB25Q46138987-E6289F8F-F1E4-4D89-A4F2-AC1B56FF5D74Q46788759-86B91065-1F74-47BE-9611-ADDA258ADDA9Q47558316-545A3A20-994F-4666-A433-12F2DD4F9530Q48302996-ED4581DF-43D0-4B15-9312-4659E55FB739Q50070347-2FEC29A6-7B80-4F02-99C8-3676B9EAA31D
P2860
Primary immunodeficiency diseases worldwide: more common than generally thought.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Primary immunodeficiency diseases worldwide: more common than generally thought.
@en
Primary immunodeficiency diseases worldwide: more common than generally thought.
@nl
type
label
Primary immunodeficiency diseases worldwide: more common than generally thought.
@en
Primary immunodeficiency diseases worldwide: more common than generally thought.
@nl
prefLabel
Primary immunodeficiency diseases worldwide: more common than generally thought.
@en
Primary immunodeficiency diseases worldwide: more common than generally thought.
@nl
P2093
P2860
P50
P1476
Primary immunodeficiency diseases worldwide: more common than generally thought.
@en
P2093
Ahmed Aziz Bousfiha
Fatima Ailal
Ibtihal Benhsaien
Leïla Jeddane
P2860
P2888
P356
10.1007/S10875-012-9751-7
P577
2012-07-31T00:00:00Z